Geron reported $238.16M in Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Amgen AMGN:US USD 63.7B 4.41B
Bio Techne TECH:US USD 2.35B 55.92M
Cti Biopharma CTIC:US USD 123.47M 11.07M
Cytokinetics CYTK:US USD 1.08B 304.24M
Esperion Therapeutics ESPR:US USD 312.83M 8.85M
Exelixis EXEL:US USD 2.96B 79.97M
Genmab GEN:DC DKK 30.69B 3.21B
Gilead Sciences GILD:US USD 62.56B 313M
Macrogenics MGNX:US USD 195.35M 22.7M
Novartis NOVN:VX USD 118.46B 4.45B
Novavax NVAX:US USD 2.27B 355.56M
Pain Therapeutics PTIE:US USD 207.29M 20.1M
Seattle Genetics SGEN:US USD 3.62B 11.26M
YTE INCY:US USD 5.51B 191.18M